TDMS Study 99033-02 Pathology Tables
NTP STATISTICAL ANALYSIS OF PRIMARY TUMORS REPORT: PEIRPT08 LAB: BIORELIANCE TRANSGENIC MODEL EVALUATION II (ASPARTAME) DATE: 03/05/03 EXPERIMENT: 99033 TEST: 02 TIME: 11:36:03 TEST TYPE: 26-39 WEEKS CAGES FROM 0000 TO LAST CAGE PAGE: 1 CONT: N01-ES-65406 ROUTE: DOSED FEED NTP C#: C99033 PATHOLOGIST: LANNING, LYNDA CAS: 22839-47-0 ------------------------------------------------------------------------------------------------------------------------------------ FINAL #3/P53 MICE REASONS FOR REMOVAL: ALL REMOVAL DATE RANGE: ALL TREATMENT GROUPS: INCLUDE ALL NTP STATISTICAL ANALYSIS OF PRIMARY TUMORS REPORT: PEIRPT08 LAB: BIORELIANCE TRANSGENIC MODEL EVALUATION II (ASPARTAME) DATE: 03/05/03 EXPERIMENT: 99033 TEST: 02 TIME: 11:36:03 TEST TYPE: 26-39 WEEKS CAGES FROM 0000 TO LAST CAGE CONT: N01-ES-65406 ROUTE: DOSED FEED NTP C#: C99033 PATHOLOGIST: LANNING, LYNDA CAS: 22839-47-0 Mice(P53 Heterozygous Transgenic) ----------------------------- FOR ALL DOSES THE TUMOR RATES IN THE FOLLOWING TISSUES/ORGANS ARE BASED ON NUMBER OF TISSUES EXAMINED. IN OTHER TISSUES/ORGANS RATES ARE BASED ON THE NUMBER OF ANIMALS NECROPSIED. --------------- Liver Pituitary Gland Prostate Thyroid Gland NTP STATISTICAL ANALYSIS OF PRIMARY TUMORS REPORT: PEIRPT08 LAB: BIORELIANCE TRANSGENIC MODEL EVALUATION II (ASPARTAME) DATE: 03/05/03 EXPERIMENT: 99033 TEST: 02 TIME: 11:36:03 TEST TYPE: 26-39 WEEKS CAGES FROM 0000 TO LAST CAGE CONT: N01-ES-65406 ROUTE: DOSED FEED NTP C#: C99033 PATHOLOGIST: LANNING, LYNDA CAS: 22839-47-0 SUMMARY OF STATISTICALLY SIGNIFICANT (P